Literature DB >> 17652962

Increased translocator protein (TSPO) mRNA levels in colon but not in rectum carcinoma.

I Königsrainer1, U F Vogel, S Beckert, K Sotlar, S Coerper, A Braun, N Lembert, W Steurer, A Königsrainer, S Kupka.   

Abstract

BACKGROUND: The peripheral-type benzodiazepine receptor or translocator protein (TSPO) is an 18-kDa protein involved in cell proliferation and apoptosis. TSPO was shown to be overexpressed in malignant tumors and cancer cell lines, correlating with enhanced malignant behavior. The present study analyzed the role of TSPO in patients with colorectal carcinomas.
METHODS: Tumor tissues and corresponding normal mucosa from 55 patients who underwent resection for colorectal carcinomas were analyzed for TSPO expression in correlation to GAPDH expression(glyceraldehyde-3-phosphate dehydrogenase) using a multiplex RT-PCR assay.
RESULTS: TSPO was overexpressed in 67% of the tumors in comparison to corresponding normal mucosa, and positivity as well as expression levels in colon carcinomas were significantly higher than in the rectum carcinomas. In contrast, TSPO expression was not different in intermediate versus high-grade tumors or in lymph node-positive versus -negative patients.
CONCLUSION: The differences in TSPO expression between colon and rectum carcinoma may imply that these tumors are of different biological behavior. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652962     DOI: 10.1159/000106380

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  6 in total

1.  Overexpression of translocator protein in inflammatory bowel disease: potential diagnostic and treatment value.

Authors:  Mariano A Ostuni; Leeyah Issop; Gabriel Péranzi; Francine Walker; Magali Fasseu; Carole Elbim; Vassilios Papadopoulos; Jean-Jacques Lacapere
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

2.  Deciphering the involvement of iron targets in colorectal cancer: a network biology approach.

Authors:  Abdul Arif Khan; Mohd Tashfeen Ashraf; Fahad M Aldakheel; Ayca Sayi Yazgan; Rana Zaidi
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

3.  Translocator Protein-Mediated Stabilization of Mitochondrial Architecture during Inflammation Stress in Colonic Cells.

Authors:  Leeyah Issop; Mariano A Ostuni; Sunghoon Lee; Mireille Laforge; Gabriel Péranzi; Pierre Rustin; Jean-François Benoist; Jérome Estaquier; Vassilios Papadopoulos; Jean-Jacques Lacapère
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

4.  Neuroinflammation in Low-Level PM2.5-Exposed Rats Illustrated by PET via an Improved Automated Produced [18F]FEPPA: A Feasibility Study.

Authors:  Mei-Fang Cheng; Tsun-Jen Cheng; Yue Leon Guo; Ching-Hung Chiu; Hung-Ming Wu; Ruoh-Fang Yen; Ya-Yao Huang; Wen-Sheng Huang; Chyng-Yann Shiue
Journal:  Mol Imaging       Date:  2022-06-07       Impact factor: 3.250

5.  Mitochondrial translocator protein deficiency exacerbates pathology in acute experimental ulcerative colitis.

Authors:  Isabel A Jimenez; Allison P Stilin; Kanako Morohaku; Mahmoud H Hussein; Prasanthi P Koganti; Vimal Selvaraj
Journal:  Front Physiol       Date:  2022-08-19       Impact factor: 4.755

6.  Translocator Protein (TSPO) as a Potential Biomarker in Human Cancers.

Authors:  Nimisha H Bhoola; Zukile Mbita; Rodney Hull; Zodwa Dlamini
Journal:  Int J Mol Sci       Date:  2018-07-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.